Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer Chun Chieh Lin, PhD, MBA, Matthew P. Smeltzer, MStat, PhD, Ahmedin Jemal, DVM, PhD, Raymond U. Osarogiagbon, MBBS The Annals of Thoracic Surgery Volume 104, Issue 4, Pages 1161-1170 (October 2017) DOI: 10.1016/j.athoracsur.2017.04.033 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Patient selection schema. (NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery 2017 104, 1161-1170DOI: (10.1016/j.athoracsur.2017.04.033) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Margin-positive rate by stage. The Annals of Thoracic Surgery 2017 104, 1161-1170DOI: (10.1016/j.athoracsur.2017.04.033) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier survival curves by facility performance category: underperforming (blue); nonoutlier (red); and outperforming (green). Crosses indicate censored; log rank p less than 0.0001. The Annals of Thoracic Surgery 2017 104, 1161-1170DOI: (10.1016/j.athoracsur.2017.04.033) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions